Cambridge Investment Research Advisors
REVS icon

Cambridge Investment Research Advisors’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio REVS Stock Details REVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
35,330
+8,918
+34% +$275K ﹤0.01% 2050
2026
Q1 		$756K Buy
+26,412
New +$770K ﹤0.01% 2420
2025
Q4 		– Sell
-17,442
Closed -$488K – 3936
2025
Q3 		$488K Buy
17,442
+1,284
+8% +$34.9K ﹤0.01% 2701
2025
Q2 		$425K Sell
16,158
-26,792
-62% -$665K ﹤0.01% 2685
2025
Q1 		$1.08M Buy
42,950
+413
+1% +$10.5K ﹤0.01% 1797
2024
Q4 		$1.05M Buy
42,537
+9,730
+30% +$251K ﹤0.01% 1831
2024
Q3 		$833K Buy
32,807
+4,511
+16% +$110K ﹤0.01% 1995
2024
Q2 		$659K Sell
28,296
-980
-3% -$22.8K ﹤0.01% 2070
2024
Q1 		$702K Buy
29,276
+464
+2% +$10.4K ﹤0.01% 1988
2023
Q4 		$624K Buy
28,812
+15,102
+110% +$312K ﹤0.01% 2009
2023
Q3 		$280K Buy
13,710
+200
+1% +$4.21K ﹤0.01% 2549
2023
Q2 		$282K Buy
+13,510
New +$272K ﹤0.01% 2581

Other funds holding REVS

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $316M AUM 30.61% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return
PK
Pflug Koory Omaha, Nebraska $250M AUM 42.29% 1-Year Est. Return
DFA
DHJJ Financial Advisors Naperville, Illinois $347M AUM 22.07% 1-Year Est. Return

Cambridge Investment Research Advisors's REVS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Columbia Research Enhanced Value ETF (REVS) stake by 34% in Q2 2026, buying an estimated $275K and bringing the position to 35,330 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2050.

Cambridge Investment Research Advisors first reported a position in REVS in Q2 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Cambridge Investment Research Advisors held 35,330 shares of Columbia Research Enhanced Value ETF worth $1.11M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 8,918 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $275K.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2050 holding.
  • Cambridge Investment Research Advisors first reported a position in Columbia Research Enhanced Value ETF in Q2 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.